Checkmate Pharmaceuticals

+$0.02 (+0.19%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMPI and other ETFs, options, and stocks.

About CMPI

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies.

CEO
Alan Bash
Employees
31
Headquarters
Cambridge, Massachusetts
Founded
2015

CMPI Key Statistics

Market cap
231.40M
Price-Earnings ratio
—
Dividend yield
—
Average volume
180.41K
High today
$10.50
Low today
$10.49
Open price
$10.49
Volume
59.99K
52 Week high
$10.50
52 Week low
$2.00

CMPI Earnings

-$0.88
-$0.15
$0.57
$1.30
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure